INVESTMENTS AND RELATED PARTY TRANSACTIONS (Tables)

12 Months Ended

Dec. 31, 2014

Summary of maximum exposure to loss associated with RS Cogen

(In millions)	2014		2013
Investment in and net advances to RS Cogen	$	4.6	$	10.9
Supply contracts		38.5		40.6
Maximum exposure to loss	$	43.1	$	51.5

Schedule of reconciliation of minority partner's ownership, reported as noncontrolling interest

(In millions)	2014			2013
Noncontrolling interest at January 1, 2014	$	119.4		$	-
Net income attributable to noncontrolling interest		3.9			2.7
Other comprehensive loss attributable to noncontrolling interest (1)		(7.7	)		-
Noncontrolling interest recognized in connection with the merger		-			130.0
Distribution to noncontrolling interest		(7.7	)		(13.3	)
Noncontrolling interest at December 31, 2014	$	107.9		$	119.4

(1) Other comprehensive loss attributable to noncontrolling interest primarily relates to change in foreign currency translation adjustment.

Chlorovinyls

Schedule of related party balances

(In millions)	2014		2013		2012		Financial Statement Classification
Investment in joint venture	$	11.0	$	11.7		NA	Other long term assets
Receivables due from affiliates		5.5		5.0		NA	Accounts receivables
Amounts due to affiliates		0.4		1.9		NA	Accounts payable
Equity in earnings from joint ventures		0.6		0.8	$	0.7	Cost of sales

Building Products

Schedule of related party balances

(In millions)	2014		2013		2012		Financial Statement Classification
Investment in joint venture	$	2.5	$	2.5		NA	Other long term assets
Receivables due from affiliates		1.2		1.0		NA	Accounts receivables
Sales to affiliates		8.8		11.6	$	14.9	Sales
Equity in earnings from joint ventures		0.3		-		2.2	Cost of sales